Literature DB >> 23733954

Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth.

Xiaoyu Hu1, Pranabananda Dutta, Amy Tsurumi, Jinghong Li, Jingtong Wang, Hartmut Land, Willis X Li.   

Abstract

Tumor suppressors known to date impede cancer growth by arresting the cell cycle or promoting apoptosis. Here we show that unphosphorylated human STAT5A functions as a tumor suppressor capable of repressing multiple oncogenes via heterochromatin formation. Unphosphorylated STAT5A binds to heterochromatin protein 1α (HP1α) and stabilizes heterochromatin. Expressing unphosphorylated STAT5A or HP1α inhibits colon cancer growth in mouse xenograft models. Transcriptome profiling shows that expressing an unphosphorylatable STAT5A has similar effects to overexpressing HP1α in global gene expression. Notably, the majority of the genes commonly repressed by unphosphorylated STAT5A and HP1α have been implicated in cancer development. Finally, down-regulation, somatic mutations, and deletions of STAT5 genes are found in certain human cancers. These results suggest that unphosphorylated STAT5A may epigenetically suppress tumor growth by promoting heterochromatin formation.

Entities:  

Keywords:  Drosophila; JAK/STAT; fluorescence recovery after photobleaching (FRAP); transcription

Mesh:

Substances:

Year:  2013        PMID: 23733954      PMCID: PMC3690839          DOI: 10.1073/pnas.1221243110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Heterochromatin: new possibilities for the inheritance of structure.

Authors:  Shiv I S Grewal; Sarah C R Elgin
Journal:  Curr Opin Genet Dev       Date:  2002-04       Impact factor: 5.578

2.  Structural basis of HP1/PXVXL motif peptide interactions and HP1 localisation to heterochromatin.

Authors:  Abarna Thiru; Daniel Nietlispach; Helen R Mott; Mitsuru Okuwaki; Debbie Lyon; Peter R Nielsen; Miriam Hirshberg; Alain Verreault; Natalia V Murzina; Ernest D Laue
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

3.  Modulation of heterochromatin protein 1 dynamics in primary Mammalian cells.

Authors:  Richard Festenstein; Stamatis N Pagakis; Kyoko Hiragami; Debbie Lyon; Alain Verreault; Belaid Sekkali; Dimitris Kioussis
Journal:  Science       Date:  2003-01-31       Impact factor: 47.728

4.  Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer.

Authors:  D A Kirschmann; R A Lininger; L M Gardner; E A Seftor; V A Odero; A M Ainsztein; W C Earnshaw; L L Wallrath; M J Hendrix
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

Review 5.  ras oncogenes in human cancer: a review.

Authors:  J L Bos
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

Review 6.  The role of signal transducer and activator of transcription factors in leukemogenesis.

Authors:  David W Sternberg; D Gary Gilliland
Journal:  J Clin Oncol       Date:  2004-01-15       Impact factor: 44.544

7.  Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice.

Authors:  José Lozano; Rosie Xing; Zhenzi Cai; Heather L Jensen; Carol Trempus; Willie Mark; Ron Cannon; Richard Kolesnick
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

8.  Maintenance of stable heterochromatin domains by dynamic HP1 binding.

Authors:  Thierry Cheutin; Adrian J McNairn; Thomas Jenuwein; David M Gilbert; Prim B Singh; Tom Misteli
Journal:  Science       Date:  2003-01-31       Impact factor: 47.728

9.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

Authors:  Ethan Cerami; Jianjiong Gao; Ugur Dogrusoz; Benjamin E Gross; Selcuk Onur Sumer; Bülent Arman Aksoy; Anders Jacobsen; Caitlin J Byrne; Michael L Heuer; Erik Larsson; Yevgeniy Antipin; Boris Reva; Arthur P Goldberg; Chris Sander; Nikolaus Schultz
Journal:  Cancer Discov       Date:  2012-05       Impact factor: 39.397

10.  BRAF and RAS mutations in human lung cancer and melanoma.

Authors:  Marcia S Brose; Patricia Volpe; Michael Feldman; Madhu Kumar; Irum Rishi; Renee Gerrero; Eugene Einhorn; Meenhard Herlyn; John Minna; Andrew Nicholson; Jack A Roth; Steven M Albelda; Helen Davies; Charles Cox; Graham Brignell; Philip Stephens; P Andrew Futreal; Richard Wooster; Michael R Stratton; Barbara L Weber
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

View more
  29 in total

1.  MiRNA-1469 promotes lung cancer cells apoptosis through targeting STAT5a.

Authors:  Chengshan Xu; Ling Zhang; Hengheng Li; Zhihua Liu; Lianning Duan; Chengrong Lu
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  Diminished Jak/STAT Signaling Causes Early-Onset Aging Defects in Stem Cell Cytokinesis.

Authors:  Kari F Lenhart; Benjamin Capozzoli; Gwen S D Warrick; Stephen DiNardo
Journal:  Curr Biol       Date:  2019-01-03       Impact factor: 10.834

Review 3.  Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology.

Authors:  Carlota Recio; Borja Guerra; Miguel Guerra-Rodríguez; Haidée Aranda-Tavío; Patricia Martín-Rodríguez; Mercedes de Mirecki-Garrido; Yeray Brito-Casillas; José M García-Castellano; Ana Estévez-Braun; Leandro Fernández-Pérez
Journal:  Oncogene       Date:  2019-02-19       Impact factor: 9.867

4.  Requirement for CRIF1 in RNA interference and Dicer-2 stability.

Authors:  Su Jun Lim; Anthony Scott; Xiao-Peng Xiong; Shabnam Vahidpour; John Karijolich; Dongdong Guo; Shanshan Pei; Yi-Tao Yu; Rui Zhou; Willis X Li
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

5.  Hypothesis: Neuroendocrine Mechanisms (Hypothalamus-Growth Hormone-STAT5 Axis) Contribute to Sex Bias in Pulmonary Hypertension.

Authors:  Pravin B Sehgal; Yang-Ming Yang; Edmund J Miller
Journal:  Mol Med       Date:  2015-07-30       Impact factor: 6.354

Review 6.  Role of STAT3 in lung cancer.

Authors:  Pranabananda Dutta; Nafiseh Sabri; Jinghong Li; Willis X Li
Journal:  JAKSTAT       Date:  2015-01-20

Review 7.  Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.

Authors:  Siham Bibi; Melis Dilara Arslanhan; Florent Langenfeld; Sylvie Jeanningros; Sabine Cerny-Reiterer; Emir Hadzijusufovic; Luba Tchertanov; Richard Moriggl; Peter Valent; Michel Arock
Journal:  Haematologica       Date:  2014-03       Impact factor: 9.941

8.  A Screening Method for Identification of Heterochromatin-Promoting Drugs Using Drosophila.

Authors:  Lin Zhang; Kenny Dao; Angela Kang; Andre C Loyola; Robin Shang; Jinghong Li; Willis X Li
Journal:  J Vis Exp       Date:  2020-03-12       Impact factor: 1.355

Review 9.  The Dynamic Interface of Viruses with STATs.

Authors:  Angela R Harrison; Gregory W Moseley
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

10.  Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer.

Authors:  Alicia E Woock; Jacqueline M Grible; Amy L Olex; J Chuck Harrell; Patricija Zot; Michael Idowu; Charles V Clevenger
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.